The Association Between Chronic Musculoskeletal Pain and Clinical Outcome in Chronic Kidney Disease Patients: a Prospective Cohort Study

Overview

Journal Ren Fail

Publisher Informa Healthcare

Date 2019 Apr 25

PMID 31014149

Citations 8

Authors

Heng-Jung Hsu

I-Wen Wu

Kuang-Hung Hsu

Chiao-Yin Sun

Ming-Jui Hung

Chun-Yu Chen

Chi-Jen Tsai

Mai-Szu Wu

Chin-Chan Lee

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Chronic musculoskeletal (MS) pain is common in chronic kidney disease (CKD) patients. The association of chronic MS pain and CKD progression has not yet been established.

Method: We conducted a prospective cohort study to evaluate the association of chronic MS pain and CKD progression of pre-dialysis CKD patients.

Result: A total of 53.2% of pre-dialysis CKD patients had chronic MS pain. Patients classified as progression and non-progression had a similar prevalence of chronic MS pain at baseline, and similar baseline use of NSAIDs and Chinese herbal medicines. Univariate Cox analysis indicated that chronic MS pain and baseline NSAID or Chinese herbal medicine use were not significantly associated with progression of CKD. But multivariate Cox regression found chronic MS pain was independently significantly associated with all-cause mortality (HR, 2.912, 95% CI, 1.004-8.444; p = .049). However, serum levels of hs-CRP were similar between those chronic MS pain patients and without chronic MS pain patients (4.96 ± 9.4 vs. 4.25 ± 13.3 mg/L, p = .535).

Conclusion: The CKD patients with chronic MS pain was independently and significantly associated with all-cause mortality, but not independently and significantly associated with CKD progression and composite endpoints. The inflammatory marker-hs-CRP was similar between CKD patients with and without chronic MS pain.

Citing Articles

Development and validation of the renal dosing questionnaire (RDQ-13) for pharmacists.

Zafar R, Rehman I, Shah Y, Ming L, Hadi M, Suleiman A Medicine (Baltimore). 2024; 103(51):e41004.

PMID: 39705490 PMC: 11666209. DOI: 10.1097/MD.0000000000041004.

Prevalence and factors associated with the correlation between malnutrition and pain in hemodialysis patients.

Jaber M, Abdalla M, Mizher A, Hammoudi H, Hamed F, Sholi A Sci Rep. 2024; 14(1):14851.

PMID: 38937541 PMC: 11211339. DOI: 10.1038/s41598-024-65603-2.

Prevalence of chronic pain in hemodialysis patients and its correlation with C-reactive protein: a cross-sectional study.

Mizher A, Hammoudi H, Hamed F, Sholi A, Abutaha A, Abdalla M Sci Rep. 2023; 13(1):5293.

PMID: 37002289 PMC: 10066398. DOI: 10.1038/s41598-023-32648-8.

Pain in Hemodialysis Patients: Prevalence, Intensity, Location, and Functional Interference in Daily Activities.

Dos Santos P, Mendonca C, Noll M, Borges C, Alves P, Dias N Healthcare (Basel). 2021; 9(10).

PMID: 34683055 PMC: 8544358. DOI: 10.3390/healthcare9101375.

Omega-7 Mixed Fatty Acid Supplementation Fails to Reduce Serum Inflammatory Biomarkers: A Placebo-Controlled, Double-Blind Randomized Crossover Trial.

Sasagawa M, Boclair M, Amieux P Nutrients. 2021; 13(8).

PMID: 34444963 PMC: 8398705. DOI: 10.3390/nu13082801.

References

Guo X, Nzerue C . How to prevent, recognize, and treat drug-induced nephrotoxicity. Cleve Clin J Med. 2002; 69(4):289-90, 293-4, 296-7 passim. DOI: 10.3949/ccjm.69.4.289. View

Mapes D, Lopes A, Satayathum S, McCullough K, Goodkin D, Locatelli F . Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003; 64(1):339-49. DOI: 10.1046/j.1523-1755.2003.00072.x. View

Kimmel P, Emont S, Newmann J, Danko H, Moss A . ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis. 2003; 42(4):713-21. DOI: 10.1016/s0272-6386(03)00907-7. View

Davison S . Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003; 42(6):1239-47. DOI: 10.1053/j.ajkd.2003.08.025. View

El Nahas A, Bello A . Chronic kidney disease: the global challenge. Lancet. 2005; 365(9456):331-40. DOI: 10.1016/S0140-6736(05)17789-7. View

Huerta C, Castellsague J, Varas-Lorenzo C, Rodriguez L . Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005; 45(3):531-9. DOI: 10.1053/j.ajkd.2004.12.005. View

Patel S, Peterson R, Kimmel P . The impact of social support on end-stage renal disease. Semin Dial. 2005; 18(2):98-102. DOI: 10.1111/j.1525-139X.2005.18203.x. View

Shayamsunder A, Patel S, Jain V, Peterson R, Kimmel P . Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patients. Semin Dial. 2005; 18(2):109-18. DOI: 10.1111/j.1525-139X.2005.18218.x. View

Mercadante S, Ferrantelli A, Tortorici C, Lo Cascio A, Lo Cicero M, Cutaia I . Incidence of chronic pain in patients with end-stage renal disease on dialysis. J Pain Symptom Manage. 2005; 30(4):302-4. DOI: 10.1016/j.jpainsymman.2005.08.010. View

10.

Davison S, Jhangri G . The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage. 2005; 30(5):465-73. DOI: 10.1016/j.jpainsymman.2005.05.013. View

11.

Gooch K, Culleton B, Manns B, Zhang J, Alfonso H, Tonelli M . NSAID use and progression of chronic kidney disease. Am J Med. 2007; 120(3):280.e1-7. DOI: 10.1016/j.amjmed.2006.02.015. View

12.

Schiffrin E, Lipman M, Mann J . Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007; 116(1):85-97. DOI: 10.1161/CIRCULATIONAHA.106.678342. View

13.

Cohen S, Patel S, Khetpal P, Peterson R, Kimmel P . Pain, sleep disturbance, and quality of life in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2007; 2(5):919-25. DOI: 10.2215/CJN.00820207. View

14.

Silverstein D . Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2008; 24(8):1445-52. DOI: 10.1007/s00467-008-1046-0. View

15.

Torrance N, Elliott A, Lee A, Smith B . Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain. 2009; 14(4):380-6. DOI: 10.1016/j.ejpain.2009.07.006. View

16.

Pham P, Dewar K, Hashmi S, Toscano E, Pham P, Pham P . Pain prevalence in patients with chronic kidney disease. Clin Nephrol. 2010; 73(4):294-9. View

17.

Stevens L, Schmid C, Greene T, Zhang Y, Beck G, Froissart M . Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010; 56(3):486-95. PMC: 2926290. DOI: 10.1053/j.ajkd.2010.03.026. View

18.

Kelly K, Dominguez J . Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol. 2010; 32(5):469-75. DOI: 10.1159/000320749. View

19.

Smith D, Wilkie R, Uthman O, Jordan J, McBeth J . Chronic pain and mortality: a systematic review. PLoS One. 2014; 9(6):e99048. PMC: 4047043. DOI: 10.1371/journal.pone.0099048. View

20.

Caravaca F, Gonzales B, Bayo M, Luna E . Musculoskeletal pain in patients with chronic kidney disease. Nefrologia. 2016; 36(4):433-40. DOI: 10.1016/j.nefro.2016.03.024. View